Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026

Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) will report first quarter 2026 financial results on April 21, 2026 before the market opens and will host a conference call at 8:30 a.m. ET.

The live webcast, earnings release, dial‑in numbers, passcode, and replay details will be posted at the company investor website. Telephone replay is available from about 10:30 a.m. ET on April 21 until midnight ET on May 5, 2026.

Investors are encouraged to review the company's SEC filings for risk factors and historical financial information.

News Market Reaction – DGX

-0.55%

1 alert

-0.55% News Effect

On the day this news was published, DGX declined 0.55%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Earnings release date: April 21, 2026 Conference call time: 8:30 a.m. Eastern Time US/Canada dial-in: 888-455-0391 +5 more

8 metrics

Earnings release date April 21, 2026 Q1 2026 financial results to be reported before market open

Conference call time 8:30 a.m. Eastern Time Start time of Q1 2026 results call

US/Canada dial-in 888-455-0391 Domestic access number for the earnings conference call

International dial-in 773-756-0467 International access number for the earnings conference call

Call passcode 7895081 Passcode required for live Q1 2026 conference call

Replay domestic number 866-388-5361 US replay access for the Q1 2026 call

Replay international number 203-369-0416 International replay access for the Q1 2026 call

Replay availability window Apr 21, 2026–May 5, 2026 Telephone replay period for the Q1 2026 call

Market Reality Check

Price: $195.72 Vol: Volume 497,676 with relat...

low vol

$195.72 Last Close

Volume Volume 497,676 with relative volume 0.64 indicates trading below recent average ahead of the earnings date announcement. low

Technical Shares at $195.22 are trading above the 200-day MA of $183.26, indicating a pre-existing upward bias into the Q1 release.

Peers on Argus

DGX was down 1.7% while key peers showed mixed, mostly modest moves: LH -0.75%, ...

DGX was down 1.7% while key peers showed mixed, mostly modest moves: LH -0.75%, WAT -1.48%, MTD -0.20%, NTRA +0.13%, PKI 0.00%, suggesting stock-specific trading rather than a clear sector rotation.

Previous Earnings date Reports

2 past events · Latest: Jan 08 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	Move	Catalyst
Jan 08	Earnings date notice	Neutral	-0.2%	Announced timing and access details for Q4 and FY 2025 results call.
Dec 09	Earnings date notice	Neutral	-1.2%	Provided scheduling and access context tied to financial and operating update.

Pattern Detected

Past earnings date announcements for DGX have seen modest negative reactions, with an average move of -0.71% across similar prior releases.

Recent Company History

Over recent months, Quest Diagnostics has paired financial disclosures with strategic moves. On February 10, 2026, it reported strong FY 2025 results, revenues of $11.04 billion, adjusted EPS of $9.85, and gave 2026 guidance of $11.70–$11.82 billion in revenues, prompting a 7.37% gain. The company also announced management changes and technology initiatives. Against this backdrop, the new Q1 2026 earnings date continues the cadence of scheduled financial communication.

Historical Comparison

-0.7% avg move · In the past, DGX earnings date announcements produced an average move of -0.71%, suggesting these sc...

earnings date

-0.7%

Average Historical Move earnings date

In the past, DGX earnings date announcements produced an average move of -0.71%, suggesting these scheduling notices typically drew only modest market reactions.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2025-06-20

DGX has an effective S-3ASR automatic shelf registration filed on June 20, 2025, allowing it to issue various debt securities on a delayed or continuous basis under Rule 415, with specific terms and pricing to be set in future prospectus supplements.

Market Pulse Summary

This announcement schedules Quest Diagnostics’ Q1 2026 earnings release for April 21, 2026, with a c...

Analysis

This announcement schedules Quest Diagnostics’ Q1 2026 earnings release for April 21, 2026, with a conference call at 8:30 a.m. ET. Historical DGX earnings date notices have produced modest average moves of -0.71%, while full results and guidance, such as the February 10, 2026 update, have been more impactful. Investors reviewing this type of notice typically focus on the upcoming financials, prior guidance ranges, and any existing capital-raising flexibility from the company’s effective debt shelf registration.

Key Terms

securities and exchange commission

1 terms

securities and exchange commission regulatory

"read the company's periodic reports on file with the Securities and Exchange Commission"

A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

AI-generated analysis. Not financial advice.

SECAUCUS, N.J., March 19, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report first quarter 2026 financial results on Tuesday, April 21, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.

The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode: "7895081." The earnings release and live webcast will be posted on www.QuestDiagnostics.com/investor. The company suggests participants dial in approximately 10 minutes before the call.

A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or by phone at 866-388-5361 for domestic callers or 203-369-0416 for international callers; no passcode is required. Telephone replays will be available from approximately 10:30 a.m. Eastern Time on April 21, 2026, until midnight Eastern Time on May 5, 2026.

Anyone listening to the call is encouraged to read the company's periodic reports on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.

About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors, and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 57,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-release-first-quarter-financial-results-on-april-21-2026-302717761.html

SOURCE Quest Diagnostics

FAQ

When will Quest Diagnostics (DGX) announce Q1 2026 results and what time is the call?

Quest Diagnostics will announce Q1 2026 results on April 21, 2026, before the market opens. According to Quest Diagnostics, the company will hold a conference call beginning at 8:30 a.m. Eastern Time that day to discuss the results and answer questions.

How can investors access the Quest Diagnostics (DGX) April 21, 2026 earnings call and webcast?

Investors can access the earnings call by phone or live webcast on the investor website. According to Quest Diagnostics, dial‑in numbers and a live webcast link are available at the company's investor site, www.QuestDiagnostics.com/investor.

What dial‑in numbers and passcode are provided for the Quest Diagnostics (DGX) Q1 2026 call?

Domestic callers can dial 888‑455‑0391 and international callers 773‑756‑0467 using the passcode 7895081. According to Quest Diagnostics, participants are advised to dial in about 10 minutes early to ensure connection before the 8:30 a.m. ET start.

Will there be a replay of the Quest Diagnostics (DGX) April 21, 2026 earnings call and how long is it available?

Yes, a replay will be available online and by telephone through May 5, 2026. According to Quest Diagnostics, telephone replay runs from about 10:30 a.m. ET on April 21 until midnight ET on May 5, 2026, with no passcode required.

Where will Quest Diagnostics (DGX) publish its Q1 2026 earnings release and presentation materials?

The company will post the earnings release and webcast materials on its investor website. According to Quest Diagnostics, all results, the live webcast link, and replay information will be available at www.QuestDiagnostics.com/investor.

Should shareholders review SEC filings before listening to the Quest Diagnostics (DGX) April 21 call?

Yes. Shareholders are encouraged to review the company's SEC filings, including risk factors and historical results. According to Quest Diagnostics, reviewing periodic reports provides context on risks, operations, and financial condition prior to the earnings discussion.